Dementia scientists express fears that Brexit will result in loss of research funding

Despite government reassurances that British businesses and universities will have certainty over future research funding in the face of Brexit, concerns are coming forward that cessation of European Union funding – particularly under the Horizon 2020 scheme - will impact R&D activities in the UK.

Today, Alzheimer’s Research UK is calling for access to European Union funding programs to be made a priority in Brexit negotiations, as a poll of dementia scientists highlights fears that Britain’s exit from the EU will lead to a loss of funding for research.

The survey, carried out by the UK’s leading dementia research charity, highlights a range of concerns about the impact of the EU referendum result – including a loss of funding, a drop in the UK’s standing as an international leader in research, and the impact on scientists’ ability to move between labs and collaborate.